IperionX Limited - IPX

IPX Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
IPX	-0.9	-6.1	3.5	64.5	75.0	152.0	241.5	241.5	241.5	241.5
S&P 500	-1.3	-2.3	0.5	5.7	10.7	30.1	25.2	88.0	187.6	33142.5

Compare IPX with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	IPX
name	IperionX Limited
price	24.04
changes percentage	-0.95
change	-0.23
day low	23.70
day high	24.64
year high	26.55
year low	8.53
market cap	748614519
price avg 50	21.75
price avg 200	16.38
exchange	NASDAQ
volume	47754
avg volume	35393
open	24
previous close	24.27
eps	-1.07
pe	-22.47
earnings announcement	2025-03-13T02:00:00.000+0000
shares outstanding	31140371
timestamp	2024-11-15 21:00:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 35.3%

Overall Quarterly Financial Health: 16.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001898601
revenue	0	0	NaN
gross profit	0	0	NaN
gross profit ratio	0	0	NaN
research and development expenses	5600653	3205162	74.74
operating expenses	17661555	21870007	-19.24
interest income	139697	24042	481.05
interest expense	88138	45541	93.54
ebitda	-17034854	-21699265	21.50
ebitdaratio	0	0	NaN
operating income	-17461388	-21852699	20.10
operating income ratio	0	0	NaN
net income	-17367525	-21447011	19.02
net income ratio	0	0	NaN
eps	-1.03	-1.59	35.35

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 6 million in 2023 from 3 million in 2022 representing a change of 74.74%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 18 million in 2023 from 22 million in 2022 representing a change of -19.24%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Earnings per Share (EPS): EPS increased to -1.03 in 2023 from -1.03 in 2022 representing a change of 35.35%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -17 million in 2023 from -22 million in 2022 representing a change of 21.5%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to -17 million in 2023 from -22 million in 2022 representing a change of 20.1%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -17 million in 2023 from -21 million in 2022 representing a change of 19.02%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q3	Q/Q change %
0001898601
revenue	0	0	NaN
gross profit	-353279	0	NaN
gross profit ratio	0	0	NaN
research and development expenses	2474.57	2474.57	0.00
operating expenses	6248.45	6248.45	0.00
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	-6217.27	-6204.17	-0.21
ebitdaratio	0	0	NaN
operating income	-6248.45	-6248.45	0.00
operating income ratio	0	0	NaN
net income	-11342726	-5674.31	-199,796.02
net income ratio	0	0	NaN
eps	-0.0	-0.03	98.80

Overall Score of Quarterly Income Statement

None

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001898601
total assets	55435894	22803535	143.10
total liabilities	4096299	2240307	82.85
total equity	51339595	20563228	149.67
cash and cash equivalents	33157356	11937941	177.75
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	41548021	12754731	225.75
total non current assets	13887873	10048804	38.20
total current liabilities	3051381	1647619	85.20
total non current liabilities	1044918	592688	76.30
common stock	112959638	58764248	92.23
retained earnings	-73882050	-52196828	-41.55
total debt	1490673	975314	52.84

Overall Score of Annual Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 55 million in 2024 from 23 million in 2023 representing a change of 143.1%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 51 million in 2024 from 21 million in 2023 representing a change of 149.67%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 33 million in 2024 from 12 million in 2023 representing a change of 177.75%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 42 million in 2024 from 13 million in 2023 representing a change of 225.75%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 113 in 2024 from 59 in 2023 representing a change of 92.23%. This indicates an increase in ownership interest.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 4 million in 2024 from 2 million in 2023 representing a change of 82.85%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 3 million in 2024 from 2 million in 2023 representing a change of 85.2%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to -74 million in 2024 from -52 million in 2023 representing a change of -41.55%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 1 million in 2024 from 1 million in 2023 representing a change of 52.84%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q3	Q/Q change %
0001898601
total assets	55435894	55435894	0.00
total liabilities	4096299	4096299	0.00
total equity	51339595	51339595	0.00
cash and cash equivalents	33157356	33157356	0.00
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	41548021	41548021	0.00
total non current assets	13887873	13887873	0.00
total current liabilities	3051381	3051381	0.00
total non current liabilities	1044918	1044918	0.00
common stock	112959638	112959000	0.00
retained earnings	-73882050	-73882050	0.00
total debt	1490673	24893	5,888.32

Overall Score of Quarterly Balance Sheet

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Common Stock: Common Stock increased to 113 in 2024Q4 from 113 in 2024Q3 representing a change of 0.0%. This indicates an increase in ownership interest.

• 📉 Negative Indicators

  Total Debt: Total Debt increased to 1 million in 2024Q4 from 0 million in 2024Q3 representing a change of 5888.32%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001898601
net change in cash	21219415	6279000	237.94
operating cash flow	-18675271	-15589000	-19.80
free cash flow	-26676715	-17891000	-49.11
capital expenditure	-8069652	-2302000	-250.55
depreciation and amortization	648218	426534	51.97
deferred income tax	0	0	NaN
stock based compensation	3791.54	2589413	-99.85
accounts payables	0	-677734	100.00
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-8069652	-2302000	-250.55
net cash used for investing activites	-6529569	-6455000	-1.16
debt repayment	-423836	-518254	18.22
common stock issued	48331724	29921945	61.53
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	46592163	28425000	63.91
cash at end of period	33157356	11938000	177.75
accounts receivables	0	-647189	100.00
cash at beginning of period	11937941	5659000	110.95

Overall Score of Annual Cashflow Statement

None

Detailed Analysis

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0001898601
operating cash flow	0	-5316.1	100.00
free cash flow	-2830000	-3411316.1	17.04
capital expenditure	-2830000	-3406000	16.91
depreciation and amortization	0	322.93	-100.00
deferred income tax	0	0	NaN
stock based compensation	0	1341.73	-100.00
accounts receivables	0	-1036.81	100.00
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	2039022	-100.00
investments in property plant and equipment	-2830000	-3406000	16.91
net cash used for investing activites	-2958000	-3551000	16.70
debt repayment	-89000	-97000	8.25
common stock issued	0	29326000	-100.00
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	4037000	29051000	-86.10
net change in cash	-2757000	21099000	-113.07
cash at end of period	30400000	33154000	-8.31
cash at beginning of period	33157000	12055000	175.05

Overall Score of Quarterly Cashflow Statement

None

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-06-30	2023-06-30	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	0	0	NaN
net income per share	0	-1.03	100.00
operating cash flow per share	0	-0.93	100.00
free cash flow per share	0	-1.06	100.00
cash per share	0	0.71	-100.00
book value per share	0	1.22	-100.00
tangible book value per share	0	1.22	-100.00
shareholders equity per share	0	1.22	-100.00
interest debt per share	0	0.01	-100.00
market cap	0	122493396.15	-100.00
enterprise value	-31666683	111530769.15	-128.39
pe ratio	0	-7.05	100.00
price to sales ratio	0	0	NaN
pocfratio	0	-7.86	100.00
pfcf ratio	0	-6.85	100.00
pb ratio	0	5.96	-100.00
ptb ratio	0	5.96	-100.00
ev to sales	0	0	NaN
enterprise value over ebitda	0	-6.55	100.00
ev to operating cash flow	1.7	-7.15	123.70
ev to free cash flow	1.19	-6.23	119.04
earnings yield	None	-0.14	NaN
free cash flow yield	0	-0.15	100.00
debt to equity	0.0	0.0	-67.69
debt to assets	0.0	0.0	-66.82
net debt to ebitda	0	0.64	-100.00
current ratio	13.62	7.74	75.89
interest coverage	0	-198.11	100.00
income quality	854.95	0.89	95,572.78
dividend yield	None	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	-0.43	-0.15	-192.62
capex to revenue	0	0	NaN
capex to depreciation	12.45	5.4	130.67
stock based compensation to revenue	0	0	NaN
graham number	0	5.33	-100.00
roic	None	-0.84	NaN
return on tangible assets	None	-0.76	NaN
graham net net	0	0.59	-100.00
working capital	38496640	11107112	246.59
tangible asset value	51339595	20563228	149.67
net current asset value	37451722	10514424	256.19
invested capital	52384513	18155916	188.53
average receivables	1265202.5	125467.5	908.39
average payables	1010039	1194384	-15.43
average inventory	8460	0	NaN
days sales outstanding	0	0	NaN
days payables outstanding	0	0	NaN
days of inventory on hand	0	0	NaN
receivables turnover	None	0	NaN
payables turnover	None	0	NaN
inventory turnover	None	0	NaN
roe	None	-0.84	NaN
capex per share	0	0.14	-100.00

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 0.00 on 2024-06-30 from -7.05 on 2023-06-30, representing a change of 100.00%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-06-30 from 0.00 on 2023-06-30, representing a change of -67.69%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  Current Ratio: Current Ratio increased to 13.62 on 2024-06-30 from 7.74 on 2023-06-30, representing a change of 75.89%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-09-30 Q1	2024-06-30 Q4	Q/Q change %
IPX
calendar year	2025	2024	NaN
revenue per share	0	0	NaN
net income per share	0	-0.5	100.00
operating cash flow per share	0	-0.0	100.00
free cash flow per share	0	-0.15	100.00
cash per share	0	1.47	-100.00
book value per share	0	2.27	-100.00
tangible book value per share	0	2.27	-100.00
shareholders equity per share	0	2.27	-100.00
interest debt per share	0	0.0	-100.00
market cap	0	342677054.28	-100.00
enterprise value	None	311010371.28	NaN
pe ratio	0	-7.55	100.00
price to sales ratio	0	0	NaN
pocfratio	0	-64460.26	100.00
pfcf ratio	0	-100.45	100.00
pb ratio	0	6.67	-100.00
ptb ratio	0	6.67	-100.00
ev to sales	0	0	NaN
enterprise value over ebitda	0	-50023.66	100.00
ev to operating cash flow	0	-58503.51	100.00
ev to free cash flow	None	-91.17	NaN
earnings yield	None	-0.03	NaN
free cash flow yield	0	-0.01	100.00
debt to equity	0	0.0	-100.00
debt to assets	0	0.0	-100.00
net debt to ebitda	0	5093.35	-100.00
current ratio	0	13.62	-100.00
interest coverage	0	0	NaN
income quality	0	0.94	-100.00
dividend yield	None	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	0	-640.7	100.00
capex to revenue	0	0	NaN
capex to depreciation	0	10547.31	-100.00
stock based compensation to revenue	0	0	NaN
graham number	0	5.07	-100.00
roic	0	-0.24	100.00
return on tangible assets	0	-0.2	100.00
graham net net	0	1.36	-100.00
working capital	None	38496640	NaN
tangible asset value	None	51339595	NaN
net current asset value	None	37451722	NaN
invested capital	None	52384513	NaN
average receivables	None	1151005	NaN
average payables	None	1309067	NaN
average inventory	None	16920	NaN
days sales outstanding	0	0	NaN
days payables outstanding	0	333.49	-100.00
days of inventory on hand	0	4.31	-100.00
receivables turnover	0	0	NaN
payables turnover	0	0.27	-100.00
inventory turnover	0	20.88	-100.00
roe	0	-0.22	100.00
capex per share	0	0.15	-100.00

• Negative

  ROE: Return on Equity (ROE) increased to 0.00 on 2024-09-30 Q1 from -0.22 on 2024-06-30 Q4, representing a change of 100.00%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio decreased to 0.00 on 2024-09-30 Q1 from 13.62 on 2024-06-30 Q4, representing a change of -100.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 0.00 on 2024-09-30 Q1 from -7.55 on 2024-06-30 Q4, representing a change of 100.00%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-09-30 Q1 from 0.00 on 2024-06-30 Q4, representing a change of -100.00%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 0.44 which is lower than current price 24.04, indicates the company may be overvalued.